Grandeur Peak Global Advisors’s RxSight RXST Stock Holding History

Grandeur Peak Global Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.87M	Buy	465,592 +75,041	+19%	+$623K	0.67%	26
2025 Q4	$4.07M	Sell	390,551 -30,139	-7%	-$302K	0.55%	46
2025 Q3	$3.78M	Buy	420,690 +226,640	+117%	+$1.99M	0.51%	49
2025 Q2	$2.52M	Buy	194,050 +94,871	+96%	+$1.43M	0.3%	66
2025 Q1	$2.5M	Buy	99,179 +14,619	+17%	+$434K	0.28%	70
2024 Q4	$2.91M	Buy	+84,560	New	+$3.81M	0.26%	73

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Grandeur Peak Global Advisors's RXST Position: Q1 2026 in Review

Grandeur Peak Global Advisors increased its RxSight (RXST) stake by 19% in Q1 2026, buying an estimated $623K and bringing the position to 465,592 shares worth $2.87M. The position accounts for 0.67% of the portfolio, ranked #26.

Grandeur Peak Global Advisors first reported a position in RXST in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.07M in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Grandeur Peak Global Advisors held 465,592 shares of RxSight worth $2.87M as of Q1 2026.
Grandeur Peak Global Advisors bought 75,041 RxSight shares in Q1 2026, an estimated $623K.
RxSight made up 0.67% of Grandeur Peak Global Advisors's portfolio in Q1 2026, its #26 holding.
Grandeur Peak Global Advisors first reported a position in RxSight in Q4 2024 and has held it in 6 quarters since.
Grandeur Peak Global Advisors's RxSight position peaked at $4.07M in Q4 2025.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Grandeur Peak Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.